Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial (Q84284316)
Jump to navigation
Jump to search
scientific article published on 01 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial |
scientific article published on 01 June 2012 |
Statements
Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial (English)
Michael E Weinblatt
Clifton O Bingham
Alan M Mendelsohn
Lilianne Kim
Michael Mack
Jiandong Lu
Daniel Baker
Rene Westhovens